Why is LLY down today?

Eli Lilly's stock is down today due to a variety of factors:

1. Pharmaceutical Sector Performance: The pharmaceutical sector has seen a general dip in stock prices, with Pfizer and other companies experiencing similar declines. This suggests that there may be broader industry-specific factors at play, such as missed internal projections or external expectations.
2. Biotech Stock Performance: Biotech stocks have experienced a downturn in recent months, with interest waning as the focus shifts to other sectors. This could indicate a broader market sentiment shift away from biotech stocks.
3. Company-Specific Issues: Eli Lilly has faced its own challenges, including a reduced guidance for its top-drug's sales, which could suggest concerns about future revenue streams. Additionally, the company's stock has been affected by the overall market sentiment towards the pharmaceutical industry.

In conclusion, Eli Lilly's stock is down today due to a combination of sector-specific challenges, broader market sentiment, and company-specific issues.